Condition: Hidradenitis Suppurativa (HS) · Sponsor: Navigator Medicines, Inc.
The main objective of this study is to determine if NAV-240 works more effectively than a dummy treatment (placebo) for participants with moderate-to-severe HS. The main endpoint of this study is the percentage of participants achieving Hidradenitis Suppurativa Clinical Response (HiSCR) 75 at Week 16, meaning at least a 75% reduction in inflamed skin bumps (abscess and inflammatory nodule (AN) count) with no increase in number of abscesses or draining tunnels (channels under the skin that leak fluid or pus) compared to the baseline (start of the study). Participants will: * Receive NAV-240 dose 1, NAV-240 dose 2 or placebo as a drip into the veins (intravenous infusion). * Visit the clinic up to 9 times for checkups and tests over 22 weeks. * Complete a daily diary about their skin pain.
This description comes directly from the study's public registry record.
Associate Director, Clinical Operations · +1 415 251 7753 · info@navigatormeds.com
Vice President, Development Operations
Always discuss trial participation with your own doctor first.
| Medical Dermatology Specialist | Phoenix, Arizona, United States | Recruiting |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | Recruiting |
| Accel Research Sites Network | Maitland, Florida, United States | Recruiting |
| Floridian Research Institute | Miami, Florida, United States | Recruiting |
| Cordova Research Institute | Miami, Florida, United States | Recruiting |
| Ziaderm Research, LLC | North Miami Beach, Florida, United States | Recruiting |
| FWD Clinical Research | Tamarac, Florida, United States | Recruiting |
| MplusM - D&H Tamarac Research Center | Tamarac, Florida, United States | Recruiting |
| ForCare Clinical Research | Tampa, Florida, United States | Recruiting |
| Kentucky Advanced Medical Research LLC | Murray, Kentucky, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Recruiting |
| SKY Integrative Medical Center | Ridgeland, Mississippi, United States | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07384975